Vincerx Pharma, Inc. Accrued Liabilities, Current
Vincerx Pharma, Inc. had Accrued Liabilities, Current of $351.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2025-05-15
- 2025-03-31: Accrued Liabilities, Current $351.00K.
- 2024-12-31: Accrued Liabilities, Current $3.24M.
- 2024-09-30: Accrued Liabilities, Current $1.72M.
- 2024-06-30: Accrued Liabilities, Current $2.43M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-03-31 | $351.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $3.24M 10-Q · filed 2025-05-15 | |
| 2024-09-30 | $1.72M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.43M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.73M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.75M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $4.53M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $4.29M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $3.35M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.92M 10-K · filed 2024-03-29 | $4.92M 10-K · filed 2023-03-28 |
| 2022-09-30 | $4.45M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $4.33M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $6.05M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $4.71M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $4.67M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $2.40M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.39M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 | |
| 2020-06-30 | $115.45K 10-K · filed 2020-09-23 | |
| 2020-03-31 | $35.20K 10-Q · filed 2020-05-06 | |
| 2019-06-30 | $1.45K 10-K · filed 2020-09-23 |